| BSE: 540596 | Sector: Health care |
| NSE: ERIS | ISIN Code: INE406M01024 |
| BSE 00:00 | 27 Feb | 423.10 |
10.90 (2.64%) |
OPEN
412.75 |
HIGH
432.80 |
LOW
410.75 |
| NSE 00:00 | 27 Feb | 425.75 |
12.40 (3.00%) |
OPEN
418.40 |
HIGH
434.00 |
LOW
409.55 |
| OPEN | 412.75 |
| PREVIOUS CLOSE | 412.20 |
| VOLUME | 1395 |
| 52-Week high | 661.95 |
| 52-Week low | 357.80 |
| P/E | 19.91 |
| Mkt Cap.(Rs cr) | 5,746 |
| Buy Price | 423.10 |
| Buy Qty | 100.00 |
| Sell Price | 435.00 |
| Sell Qty | 1.00 |
Eris Lifesciences Limited was incorporated on January 25 2007. Subsequently the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9 2007. Further the company was converted into a public limited company and the name was changed to 'Eris Lifesciences Limited' on February 2 2017. The company develops manufactures and commercializes branded pharmaceutical products in s...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
5,746 | |
| EPS - TTM | () |
[*S] | 21.25 |
| P/E Ratio | (X) | [*S] | 19.91 |
| Face Value | () |
1 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 97.88 |
| P/B Ratio | () |
[*S] | 4.32 |
Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Investor Presentation
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 266.4 | 252.4 | 5.55 |
| Other Income | 8.47 | 10.29 | -17.69 |
| Total Income | 274.87 | 262.68 | 4.64 |
| Total Expenses | 189.62 | 158.87 | 19.36 |
| Operating Profit | 85.25 | 103.81 | -17.88 |
| Net Profit | 63.47 | 80.2 | -20.86 |
| Equity Capital | 13.75 | 13.75 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Glenmark Pharma. | 293.80 | -0.74 | 8291.04 |
| Proc. Gam. Heal. | 4165.95 | 0.35 | 6915.48 |
| Astrazeneca Phar | 2661.45 | 0.11 | 6653.62 |
| ERIS Lifescience | 423.10 | 2.64 | 5745.70 |
| Strides Pharma | 495.60 | 1.08 | 4439.09 |
| Granules India | 173.05 | -0.26 | 4398.93 |
| J B Chem & Pharm | 556.95 | -0.56 | 4305.22 |
|
|
|
| Date | Broker | Action | Price | Report |
| 06/11 | Prabhudas Lilladher | Accumulate | 643 |  Details |
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -2.18% | -1.71% | -3.46% | -3.70% |
| 1 Month | -16.31% | -15.77% | -3.42% | -4.01% |
| 3 Month | -2.29% | -1.88% | -3.11% | -3.86% |
| 6 Month | 11.62% | 12.26% | 5.59% | 4.75% |
| 1 Year | -30.72% | -30.15% | 10.70% | 7.65% |
| 3 Year | NA | NA | 37.94% | 30.76% |
| Today's Low/High | 410.75 |
|
432.80 |
| Week Low/High | 405.00 |
|
444.00 |
| Month Low/High | 405.00 |
|
560.00 |
| YEAR Low/High | 357.80 |
|
662.00 |
| All TIME Low/High | 357.80 |
|
896.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
